47 U.S. lawmakers have disclosed 119 AbbVie Inc. trades under the STOCK Act — 68 buys and 51 sells between 2014 and 2026. Congress has been net buyers of ABBV, and their disclosed buys are up 35.7% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of ABBV, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed ABBV buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2020-11-12 | Kenny Marchant | BUY | $1K–$15K | $97.60 | $250.82 2026-08-13 | +157.0% |
| 2020-10-13 | Debbie Dingell | BUY | $15K–$50K | $87.83 | $250.82 2026-08-13 | +185.6% |
| 2020-08-21 | Jerry Moran, | SELL | $1K–$15K | $94.86 | $250.82 2026-08-13 | +5.0% rt |
| 2020-07-09 | Thomas R Carper | SELL | $1K–$15K | $97.94 | $250.82 2026-08-13 | +45.1% rt |
| 2020-07-09 | Thomas R Carper | SELL | $1K–$15K | $97.94 | $250.82 2026-08-13 | +71.7% rt |
| 2020-06-29 | William R. Timmons IV | SELL | $1K–$15K | $96.44 | $250.82 2026-08-13 | -160.1% exit |
| 2020-06-19 | David P. Roe | BUY | $1K–$15K | $96.71 | $250.82 2026-08-13 | +159.3% |
| 2020-05-08 | Steve Chabot | BUY | $1K–$15K | $83.96 | $250.82 2026-08-13 | +198.7% |
| 2020-04-22 | Fred Upton | SELL | $15K–$50K | $81.47 | $250.82 2026-08-13 | -11.0% rt |
| 2020-04-14 | David A Perdue , Jr | SELL | $15K–$50K | $82.13 | $250.82 2026-08-13 | -205.4% exit |
| 2020-04-14 | David A Perdue , Jr | SELL | $15K–$50K | $82.13 | $250.82 2026-08-13 | -205.4% exit |
| 2020-04-14 | Kelly Loeffler | SELL | $250K–$500K | $82.13 | $250.82 2026-08-13 | +8.9% rt |
| 2020-04-07 | Kelly Loeffler | BUY | $15K–$50K | $75.39 | $250.82 2026-08-13 | +232.7% |
| 2020-04-07 | Kelly Loeffler | BUY | $1K–$15K | $75.39 | $250.82 2026-08-13 | +232.7% |
| 2020-04-03 | David P. Roe | BUY | $1K–$15K | $73.37 | $250.82 2026-08-13 | +241.9% |
| 2020-03-24 | Thomas R Carper | BUY | $1K–$15K | $67.49 | $250.82 2026-08-13 | +271.6% |
| 2020-02-27 | Robert J. Wittman | BUY | $1K–$15K | $85.42 | $250.82 2026-08-13 | +193.6% |
| 2020-02-20 | Kelly Loeffler | SELL | $1K–$15K | $94.23 | $250.82 2026-08-13 | -166.2% exit |
| 2020-02-20 | Kelly Loeffler | SELL | $1K–$15K | $94.23 | $250.82 2026-08-13 | -166.2% exit |
| 2020-02-13 | RICHARD M BURR | SELL | $15K–$50K | $95.35 | $250.82 2026-08-13 | +45.1% rt |
| 2020-02-13 | RICHARD M BURR | BUY | $1K–$15K | $95.35 | $250.82 2026-08-13 | +163.1% |
| 2019-12-23 | Kenny Marchant | BUY | $1K–$15K | $90.25 | $250.82 2026-08-13 | +177.9% |
| 2019-12-11 | Daniel Meuser | SELL | $1K–$15K | $86.70 | $250.82 2026-08-13 | -189.3% exit |
| 2019-07-15 | David A Perdue , Jr | SELL | $15K–$50K | $70.27 | $250.82 2026-08-13 | +22.8% rt |
| 2019-07-02 | Kurt Schrader | BUY | $1K–$15K | $74.23 | $250.82 2026-08-13 | +237.9% |
| 2019-07-02 | Carol Devine Miller | BUY | $15K–$50K | $74.23 | $250.82 2026-08-13 | +237.9% |
| 2019-06-25 | RICHARD M BURR | SELL | $1K–$15K | $65.70 | $250.82 2026-08-13 | -281.8% exit |
| 2019-06-25 | RICHARD M BURR | BUY | $1K–$15K | $65.70 | $250.82 2026-08-13 | +281.8% |
| 2019-02-04 | Dean Phillips | SELL | $1K–$15K | $78.53 | $250.82 2026-08-13 | -219.4% exit |
| 2018-12-06 | Jerry Moran, | BUY | $1K–$15K | $90.33 | $250.82 2026-08-13 | +177.7% |
| 2018-09-18 | Gary Palmer | SELL | $1K–$15K | $92.61 | $250.82 2026-08-13 | -170.8% exit |
| 2018-07-24 | Fred Upton | BUY | $1K–$15K | $91.54 | $250.82 2026-08-13 | +174.0% |
| 2018-06-01 | Kurt Schrader | BUY | $1K–$15K | $98.05 | $250.82 2026-08-13 | +155.8% |
| 2018-04-06 | Robert J. Wittman | SELL | $1K–$15K | $89.78 | $250.82 2026-08-13 | +51.7% rt |
| 2018-02-28 | Adam B. Schiff | BUY | $1K–$15K | $115.83 | $250.82 2026-08-13 | +116.5% |
| 2018-02-22 | Debbie Dingell | BUY | $1K–$15K | $117.56 | $250.82 2026-08-13 | +113.3% |
| 2017-12-08 | Mike Kelly | BUY | $1K–$15K | $95.95 | $250.82 2026-08-13 | +161.4% |
| 2017-11-07 | Kenneth R. Buck | SELL | $1K–$15K | $93.96 | $250.82 2026-08-13 | -166.9% exit |
| 2017-01-20 | John Hoeven | SELL | $100K–$250K | $61.15 | $250.82 2026-08-13 | +20.2% rt |
| 2016-12-16 | Katherine M. Clark | SELL | $15K–$50K | $62.22 | $250.82 2026-08-13 | -303.1% exit |
| 2016-11-23 | Kenny Marchant | BUY | $1K–$15K | $60.18 | $250.82 2026-08-13 | +316.8% |
| 2016-09-06 | F. James Sensenbrenner Jr. | SELL | $1K–$15K | $64.61 | $250.82 2026-08-13 | -288.2% exit |
| 2016-06-22 | Debbie Dingell | BUY | $1K–$15K | $60.39 | $250.82 2026-08-13 | +315.3% |
| 2016-04-01 | Kenny Marchant | BUY | $1K–$15K | $57.42 | $250.82 2026-08-13 | +336.8% |
| 2016-03-03 | E. Scott Rigell | BUY | $15K–$50K | $55.93 | $250.82 2026-08-13 | +348.4% |
| 2016-01-07 | David A Perdue , Jr | BUY | $1K–$15K | $57.21 | $250.82 2026-08-13 | +338.4% |
| 2016-01-06 | F. James Sensenbrenner Jr. | SELL | $1K–$15K | $57.38 | $250.82 2026-08-13 | -337.1% exit |
| 2015-10-29 | Kenny Marchant | BUY | $1K–$15K | $54.10 | $250.82 2026-08-13 | +363.6% |
| 2015-09-15 | Robert J. Wittman | BUY | $1K–$15K | $59.20 | $250.82 2026-08-13 | +323.7% |
| 2015-09-10 | Gary C Peters | BUY | $1K–$15K | $59.58 | $250.82 2026-08-13 | +321.0% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
47 members of the U.S. House and Senate have disclosed AbbVie Inc. transactions under the STOCK Act — 68 purchases and 51 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a ABBV purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed ABBV buys are up 35.7% versus the latest close of $250.82. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ABBV and how it performed.